down arrow

Suven Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE03QK01018
  • NSEID: SUVENPHAR
  • BSEID: 543064
INR
1,120.85
68.65 (6.52%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Net Sales
307.15
257.72
230.69
252.93
219.82
231.05
347.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
307.15
257.72
230.69
252.93
219.82
231.05
347.55
Raw Material Cost
67.04
47.08
38.30
71.43
63.52
51.16
79.77
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-11.41
4.98
25.30
12.30
8.91
6.45
21.50
Employee Cost
63.29
51.87
45.62
39.39
34.79
28.58
28.74
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
27.08
36.53
0.00
29.27
32.28
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
4.47
2.09
Other Expenses
70.53
49.78
14.46
19.93
46.52
13.16
16.21
Total Expenditure (Excl Depreciation)
189.45
153.71
150.76
179.58
153.74
133.09
180.59
Operating Profit (PBDIT) excl Other Income
117.70
104.01
79.93
73.35
66.08
97.96
166.96
Other Income
15.71
14.12
18.16
17.05
14.34
19.84
10.67
Operating Profit (PBDIT)
133.41
118.13
98.09
90.40
80.42
117.80
177.63
Interest
3.33
1.67
1.60
2.30
2.16
0.50
1.15
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
130.08
116.46
96.49
88.10
78.26
117.30
176.48
Depreciation
20.35
16.96
13.40
17.25
12.79
11.89
12.54
Profit Before Tax
109.73
99.50
83.09
70.85
65.47
105.41
163.94
Tax
26.44
17.52
22.32
17.48
18.72
25.84
43.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
83.29
81.98
60.77
53.37
46.75
79.56
120.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
83.29
81.98
60.77
53.37
46.75
79.56
120.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.41
-0.23
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
82.88
82.21
60.77
53.37
46.75
79.56
120.59
Equity Capital
25.46
25.46
25.46
25.46
25.46
25.46
25.46
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
1,952.88
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.26
3.23
2.39
2.1
1.84
3.12
4.74
Diluted Earnings per share
3.23
3.23
2.39
2.1
1.84
3.13
4.74
Operating Profit Margin (Excl OI)
38.32%
40.36%
34.65%
29.0%
30.06%
42.4%
48.04%
Gross Profit Margin
42.35%
45.19%
41.83%
34.83%
35.6%
50.77%
50.78%
PAT Margin
27.12%
31.81%
26.34%
21.1%
21.27%
34.43%
34.7%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2024 is 19.18% vs 11.72% in Sep 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2024 is 0.81% vs 35.28% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is 13.16% vs 30.13% in Sep 2024

stock-summary

Interest

QoQ Growth in quarter ended Dec 2024 is 99.40% vs 4.37% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

Compare Quarterly Results Of Suven Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
307.15
3,230.00
-2,922.85
-90.49%
Other Operating Income
0.00
0.00
0.00
Total Operating income
307.15
3,230.00
-2,922.85
-90.49%
Raw Material Cost
67.04
536.11
-469.07
-87.50%
Purchase of Finished goods
0.00
387.30
-387.30
-100.00%
(Increase) / Decrease In Stocks
-11.41
11.81
-23.22
-196.61%
Employee Cost
63.29
709.71
-646.42
-91.08%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
70.53
755.27
-684.74
-90.66%
Total Expenditure (Excl Depreciation)
189.45
2,400.20
-2,210.75
-92.11%
Operating Profit (PBDIT) excl Other Income
117.70
829.80
-712.10
-85.82%
Other Income
15.71
77.32
-61.61
-79.68%
Operating Profit (PBDIT)
133.41
907.12
-773.71
-85.29%
Interest
3.33
220.93
-217.60
-98.49%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
130.08
686.19
-556.11
-81.04%
Depreciation
20.35
192.30
-171.95
-89.42%
Profit Before Tax
109.73
497.33
-387.60
-77.94%
Tax
26.44
112.81
-86.37
-76.56%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
83.29
381.08
-297.79
-78.14%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
83.29
381.08
-297.79
-78.14%
Share in Profit of Associates
0.00
3.44
-3.44
-100.00%
Minority Interest
0.41
4.29
-3.88
-90.44%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
82.88
380.23
-297.35
-78.20%
Equity Capital
25.46
40.06
-14.60
-36.45%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.26
9.49
-6.23
-65.65%
Diluted Earnings per share
3.23
9.44
-6.21
-65.78%
Operating Profit Margin (Excl OI)
38.32%
25.69%
0.00
12.63%
Gross Profit Margin
42.35%
21.24%
0.00
21.11%
PAT Margin
27.12%
11.90%
0.00
15.22%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 307.15 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 19.18% vs 11.72% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 39.73% vs -37.86% in Dec 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 82.88 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 0.81% vs 35.28% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 77.28% vs -56.60% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 117.70 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 13.16% vs 30.13% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 78.12% vs -54.95% in Dec 2023

Quarterly - Interest
Interest 3.33 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 99.40% vs 4.37% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 54.17% vs 56.52% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.32%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023